- Copy top eToro investors automatically with CopyTrader
- Trade stocks, options, ETFs and crypto in one app
- Use a demo account to practice before investing
- See how top investors build their portfolios
Intrinsic Medicine, which develops treatments for gut-related conditions using synthetic biology-manufactured human identical milk oligosaccharide (HiMO) molecules, has cancelled plans to go public in the US. Learn more about the withdrawn IPO, and find out about similar companies in which you can invest.
On July 25, 2022, Intrinsic Medicine announced it was cancelling its plans to go public. Originally, it had planned to conduct an IPO on the Nasdaq under the ticker symbol “INRX.” Altogether, the company had planned to raise around $25 million by offering 4.2 million stocks at a price of $5.00 – $7.00.
Spartan Capital Securities, LLC was slated to act as the lead underwriter of the deal. You can read more about the IPO in this prospectus submitted to the US Securities and Exchange Commission (SEC) on May 4, 2022.
Current market conditions have been cited as the reason for for the cancellation. A future IPO date has not been announced.
Even though you won’t be able to buy Intrinsic Medicine stock, you can still invest in other biotechnology companies that develop treatments for gut-related conditions.
| Company | Stock info |
|---|---|
| Finch Therapeutics Group | NasdaqGS: FNCH |
| Seres Therapeutics | NasdaqGS: MCRB |
| Evelo Biosciences | NasdaqGS: EVLO |
| PureTech Health | NasdaqGM: PRTC |
You’ll need a brokerage account to buy and sell stocks. Here’s how it works:
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on eight different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Find out where to trade fractional shares easily.
While day traders seek to capture small but more frequent profits, swing traders spread their trades over days or weeks. See pros and cons here.
A step-by-step guide for beginners to start investing with Robinhood.
Day trading is legal, but it comes with strict rules, taxes and high risks. Follow our beginner’s guide to trade safely.
Steps to add Pattern Group stock to your portfolio, with historical pricing, volatility and earnings metrics.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Steps to owning and managing SPCX, with 24-hour and historical pricing before you buy.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Features and fees to consider before you open an account with this trading platform.
How day trading works, what to watch out for and how to pick a broker.